Point-of-care detection assay based on biomarker-imprinted polymer for different cancers: a state-of-the-art review

Bacteria-imprinted impedimetric sensor based on doping-induced nanostructured polypyrrole for determination of Escherichia coli

A simple and label-free bacteria-imprinted impedimetric (BIP) sensor for the sensitive measurement of Escherichia coli has been developed. The BIP sensor is fabricated by one-step electropolymerization of pyrrole (functional monomer), copper phthalocyanine-3, 4', 4'', 4'''-tetrasulfonic acid tetrasodium salt (CuPcTs, dopant), and target bacteria (E. coli O157:H7) on a glassy carbon electrode. After the removal of the bacterial template, the established imprinted sites on the CuPcTs-doped polypyrrole film (PPy/CuPcTs) enable the highly selective rebinding of target bacteria and the resulting impedance change of the sensing interface is used to detect the target bacteria. We found that during the electropolymerization process, CuPcTs induced pyrrole to form granular-like nanostructured PPy/CuPcTs with excellent conductivity compared with the PPy film, substantially improving the sensitivity of the proposed sensor. The sensor presented a wide detection range (102 ~ 107 CFU⋅mL-1, RSD 1.1% ~ 3.5%) with a limit of detection of 21 CFU⋅mL-1. Furthermore, the proposed sensor effectively distinguished E. coli O157:H7 from other non-target bacteria and exhibited good practicality with recoveries from 91 to 103% in spiked real samples, indicating the potential utility of the sensor in food safety and environmental monitoring.

Magnetic Nanoparticle-Based Electrochemical Sensing Platform Using Ferrocene-Labelled Peptide Nucleic Acid for the Early Diagnosis of Colorectal Cancer

Diagnostic biomarkers based on epigenetic changes such as DNA methylation are promising tools for early cancer diagnosis. However, there are significant difficulties in directly and specifically detecting methylated DNA regions. Here, we report an electrochemical sensing system based on magnetic nanoparticles that enable a quantitative and selective analysis of the methylated septin9 (mSEPT9) gene, which is considered a diagnostic marker in early stage colorectal cancer (CRC). Methylation levels of SEPT9 in CRC samples were successfully followed by the selective recognition ability of a related peptide nucleic acid (PNA) after hybridization with DNA fragments in human patients’ serums and plasma (n = 10). Moreover, this system was also adapted into a point-of-care (POC) device for a one-step detection platform. The detection of mSEPT9 demonstrated a limit of detection (LOD) value of 0.37% and interference-free measurement in the presence of branched-chain amino acid transaminase 1 (BCAT1) and SRY box transcription factor 21 antisense divergent transcript 1 (SOX21-AS1). The currently proposed functional platform has substantial prospects in translational applications of early CRC detection.